AU2013346766B2 - Effervescent tablet - Google Patents

Effervescent tablet Download PDF

Info

Publication number
AU2013346766B2
AU2013346766B2 AU2013346766A AU2013346766A AU2013346766B2 AU 2013346766 B2 AU2013346766 B2 AU 2013346766B2 AU 2013346766 A AU2013346766 A AU 2013346766A AU 2013346766 A AU2013346766 A AU 2013346766A AU 2013346766 B2 AU2013346766 B2 AU 2013346766B2
Authority
AU
Australia
Prior art keywords
effervescent tablet
solution
dissolution
effervescent
tablet according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013346766A
Other languages
English (en)
Other versions
AU2013346766A1 (en
Inventor
Silvia Boschetti
Massimiliano Rossi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati UK Ltd
Original Assignee
Eusa Pharma UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eusa Pharma UK Ltd filed Critical Eusa Pharma UK Ltd
Publication of AU2013346766A1 publication Critical patent/AU2013346766A1/en
Assigned to EUSA PHARMA (UK) LTD reassignment EUSA PHARMA (UK) LTD Request for Assignment Assignors: ARCORAL PHARMA AS
Application granted granted Critical
Publication of AU2013346766B2 publication Critical patent/AU2013346766B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/22—Gas releasing
    • A61K2800/222—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2013346766A 2012-11-16 2013-11-14 Effervescent tablet Active AU2013346766B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261727119P 2012-11-16 2012-11-16
NO20121358 2012-11-16
NO20121358 2012-11-16
US61/727,119 2012-11-16
PCT/EP2013/073857 WO2014076194A1 (en) 2012-11-16 2013-11-14 Effervescent tablet

Publications (2)

Publication Number Publication Date
AU2013346766A1 AU2013346766A1 (en) 2015-05-21
AU2013346766B2 true AU2013346766B2 (en) 2018-05-24

Family

ID=50730616

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013346766A Active AU2013346766B2 (en) 2012-11-16 2013-11-14 Effervescent tablet

Country Status (6)

Country Link
US (1) US11090259B2 (https=)
EP (1) EP2919744B1 (https=)
AU (1) AU2013346766B2 (https=)
CA (1) CA2891362C (https=)
IN (1) IN2015DN03929A (https=)
WO (1) WO2014076194A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590165B2 (en) * 2014-12-17 2023-02-28 Bausch Health Companies Inc. Formulations of calcium and phosphate for oral inflammation
GB2545007A (en) * 2015-12-03 2017-06-07 Cosmetic Warriors Ltd Composition
US9877913B2 (en) 2016-06-24 2018-01-30 Lewis H. Gross Alkalizing delivery system for promoting an optimal oral salivary pH
GR1009399B (el) * 2017-06-23 2018-11-15 Χρηστος Γεωργιου Φυτας Στοματικο διαλυμα κατα της ξηροστομιας και στοματοφαρυγγικης βλεννογονιτιδας
CN109156693A (zh) * 2018-08-06 2019-01-08 吉林大学 一种鹿茸泡腾片的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025914A1 (en) * 1995-02-24 1996-08-29 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
WO2005011639A2 (en) * 2003-07-17 2005-02-10 Menarini International Operations Luxembourg S.A. Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use
US20110014132A1 (en) * 2009-07-14 2011-01-20 Shuang Peter Liu Solid effervescent mixture for the oral absorption

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1269620A (en) * 1917-06-27 1918-06-18 William Levine Surgical tourniquet.
DE2051499A1 (de) 1969-10-20 1971-04-29 Warner Lambert Pharmaceutical Co , Morns Plains, NJ (V St A ) Aufbrausende Zusammensetzungen, die Fluond enthalten
US3651207A (en) * 1970-12-14 1972-03-21 Lafant Research Co Preparation for use in mouthwash having effervescence
US3903255A (en) 1971-05-17 1975-09-02 Rohm & Haas Effervescent potassium chloride tablet
US4127645A (en) 1976-05-21 1978-11-28 Life Savers, Inc. Effervescent tablet and method
WO1997006774A1 (en) 1995-08-08 1997-02-27 Enamelon, Inc. Remineralizing products and methods for teeth
US5993785A (en) 1996-09-18 1999-11-30 Erling Johansen Mouthwash compositions
US5817296A (en) * 1996-09-27 1998-10-06 Enamelon, Inc. Processes and compositions for the remineralization of teeth
WO1998013013A1 (en) 1996-09-27 1998-04-02 Enamelon, Inc. Improved products and methods for the remineralization and prevention of demineralization of teeth
ES2255429B1 (es) 2004-10-25 2007-08-16 Italfarmaco, S.A. Composiciones farmaceuticas bucodispersables.
US20110086108A1 (en) 2009-10-12 2011-04-14 Bartholomew Weldon Dissolving powders that can be mixed with water and used as an oral rinse
TR201004464A2 (tr) * 2010-06-03 2012-11-21 B�Lg�� Mahmut Kemik erimesi için formülasyon.
WO2012156502A2 (en) 2011-05-18 2012-11-22 Arcoral Pharma As Two component mouth rinse preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025914A1 (en) * 1995-02-24 1996-08-29 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
WO2005011639A2 (en) * 2003-07-17 2005-02-10 Menarini International Operations Luxembourg S.A. Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use
US20110014132A1 (en) * 2009-07-14 2011-01-20 Shuang Peter Liu Solid effervescent mixture for the oral absorption

Also Published As

Publication number Publication date
IN2015DN03929A (https=) 2015-10-02
AU2013346766A1 (en) 2015-05-21
US11090259B2 (en) 2021-08-17
HK1215409A1 (en) 2016-08-26
EP2919744A1 (en) 2015-09-23
US20150272873A1 (en) 2015-10-01
CA2891362C (en) 2020-04-21
WO2014076194A1 (en) 2014-05-22
EP2919744B1 (en) 2020-09-02
CA2891362A1 (en) 2014-05-22

Similar Documents

Publication Publication Date Title
EP1067905A1 (de) Brauseformulierungen
EP3368012B1 (en) Lisinopril formulations
JP2004521955A (ja) 新規置換ベンズイミダゾール製剤およびその使用方法
PT1082106E (pt) Comprimido efervescente para administração subligual, bucal e gengival de fentanil
AU2013346766B2 (en) Effervescent tablet
HU211285A9 (en) Oral dosing formulations of dideoxy purine nucleosides
ES2912897T3 (es) Formulaciones de diclofenaco y métodos de uso
CN104706616A (zh) 泡腾组合物
GB2564444A (en) Liquid pharmaceutical composition of flecainide
EP1651191B1 (en) Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use
JPH09502709A (ja) エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物
GB2619970A (en) An orodispersible pharmaceutical composition of baclofen and its process of preparation
HK1215409B (en) Effervescent tablet
KR101175120B1 (ko) 나테글리니드 함유 제제
ES2822659T3 (es) Comprimido efervescente
US12539314B1 (en) Aqueous oral compositions including potassium chloride
CN114129512B (zh) 一种可口服用萘普生溶液制剂及其制备方法与应用
US20260090985A1 (en) Oral mucosal formulations of aspirin
KR20070091041A (ko) 포비돈요오드를 함유하는 구강내 붕괴형의 고형 제제
KR101360869B1 (ko) 구연산칼륨, 구연산 및 탄산수소칼륨을 주성분으로 하는 요로결석 치료용 발포성 정제 조성물 및 그를 사용한 발포성 정제의 제조방법
WO2012156502A2 (en) Two component mouth rinse preparation
WO2020121027A1 (es) Composiciones de alprazolam amorfo con actividad ansiolítica, con etilcelulosa y crospovidona, y procedimientos correspondientes
RU2276982C2 (ru) Средство, обладающее противовоспалительным, анальгетическим, жаропонижающим действием в форме таблетки
KR20160012921A (ko) 블로난세린을 포함하는 구강 속붕해성 제제
CN121868237A (zh) 一种枸橼酸爱地那非口崩片及其制备方法和应用

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: EUSA PHARMA (UK) LTD

Free format text: FORMER APPLICANT(S): ARCORAL PHARMA AS

FGA Letters patent sealed or granted (standard patent)